Paper42943535PubMed
Clinical Characteristics of Coccidioidomycosis in Patients with Hepatitis C-Associated Cirrhosis.
Shepard R and 4 others. Microorganisms, 2026.
Cite this record
ConductScience Library. Clinical Characteristics of Coccidioidomycosis in Patients with Hepatitis C-Associated Cirrhosis. Papers, record 42943535. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42943535
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinical Characteristics of Coccidioidomycosis in Patients with Hepatitis C-Associated Cirrhosis.
- Journal
- Microorganisms
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-28
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15938383 | [Treatment of hepatitis C virus infection]. | Praxis (Bern 1994) | 2005 | https://conductscience.org/library/papers/15938383 | PubMed |
| 2 | 40246701 | Impact of glycemic control on coccidioidomycosis outcomes in patients with underlying diabetes mellitus in central California. | Med Mycol | 2025 | https://conductscience.org/library/papers/40246701 | PubMed |
| 3 | 41580284 | Coccidioidomycosis in cirrhosis: A high-risk syndrome with severe outcomes. | Am J Med Sci | 2026 | https://conductscience.org/library/papers/41580284 | PubMed |
| 4 | 34133861 | The Evolving Challenge of Infections in Cirrhosis. | N Engl J Med | 2021 | https://conductscience.org/library/papers/34133861 | PubMed |
| 5 | 36983473 | Case Series of End-Stage Liver Disease Patients with Severe Coccidioidomycosis. | J Fungi (Basel) | 2023 | https://conductscience.org/library/papers/36983473 | PubMed |
| 6 | 12884198 | Incidence and prevalence of coccidioidomycosis in patients with end-stage liver disease. | Liver Transpl | 2003 | https://conductscience.org/library/papers/12884198 | PubMed |
| 7 | 39189034 | Clinical Characteristics and Mortality Risks Among Patients With Culture-Proven Coccidioidomycosis Who Are Critically Ill: A Multicenter Study in an Endemic Region. | Open Forum Infect Dis | 2024 | https://conductscience.org/library/papers/39189034 | PubMed |
| 8 | 35233706 | Coccidioidomycosis: A Contemporary Review. | Infect Dis Ther | 2022 | https://conductscience.org/library/papers/35233706 | PubMed |
| 9 | 21745274 | Hepatitis C virus infection in USA: an estimate of true prevalence. | Liver Int | 2011 | https://conductscience.org/library/papers/21745274 | PubMed |
| 10 | 30959825 | Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection. | Cells | 2019 | https://conductscience.org/library/papers/30959825 | PubMed |
| 11 | 10492320 | Hepatic hydrothorax: pathogenesis, diagnosis, and management. | Am J Med | 1999 | https://conductscience.org/library/papers/10492320 | PubMed |
| 12 | 27339680 | Infections in Liver Disease. | Crit Care Clin | 2016 | https://conductscience.org/library/papers/27339680 | PubMed |
| 13 | 15118543 | Coccidioidomycosis: a descriptive survey of a reemerging disease. Clinical characteristics and current controversies. | Medicine (Baltimore) | 2004 | https://conductscience.org/library/papers/15118543 | PubMed |
| 14 | 27470238 | 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis. | Clin Infect Dis | 2016 | https://conductscience.org/library/papers/27470238 | PubMed |
| 15 | 28074358 | Genotype 3 Infection: The Last Stand of Hepatitis C Virus. | Drugs | 2017 | https://conductscience.org/library/papers/28074358 | PubMed |
| 16 | 35792761 | Liver cirrhosis and immune dysfunction. | Int Immunol | 2022 | https://conductscience.org/library/papers/35792761 | PubMed |
| 17 | 11229838 | Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996. | Clin Infect Dis | 2001 | https://conductscience.org/library/papers/11229838 | PubMed |
| 18 | 34242330 | Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy. | PLoS One | 2021 | https://conductscience.org/library/papers/34242330 | PubMed |
| 19 | 14586893 | Hepatitis C pathogenesis: mechanisms of viral clearance and liver injury. | Liver Transpl | 2003 | https://conductscience.org/library/papers/14586893 | PubMed |
| 20 | 34016286 | Coccidioidomycosis. | Infect Dis Clin North Am | 2021 | https://conductscience.org/library/papers/34016286 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42943535
GET https://conductscience.org/api/papers/v1/42943535/references?page=2